Literature DB >> 17000644

Distinct and overlapping sets of SUMO-1 and SUMO-2 target proteins revealed by quantitative proteomics.

Alfred C O Vertegaal1, Jens S Andersen, Stephen C Ogg, Ronald T Hay, Matthias Mann, Angus I Lamond.   

Abstract

The small ubiquitin-like modifier (SUMO) family in vertebrates includes three different family members that are conjugated as post-translational modifications to target proteins. SUMO-2 and -3 are nearly identical but differ substantially from SUMO-1. We used quantitative proteomics to investigate the target protein preferences of SUMO-1 and SUMO-2. HeLa cells were established that stably express His6-SUMO-1 or His6-SUMO-2. These cell lines and control HeLa cells were labeled with stable arginine isotopes, and His6-SUMOs were enriched from lysates using immobilized metal affinity chromatography. 53 SUMO-conjugated proteins were identified, including 44 novel SUMO targets. 25 proteins were preferentially conjugated to SUMO-1, 19 were preferentially conjugated to SUMO-2, and nine proteins were conjugated to both SUMO-1 and SUMO-2. SART1 was confirmed by immunoblotting to have both SUMO-1- and SUMO-2-linked forms at similar levels. SUMO-1 and SUMO-2 are thus shown to have distinct and overlapping sets of target proteins, indicating that SUMO-1 and SUMO-2 may have both redundant and non-redundant cellular functions. Interestingly, 14 of the 25 SUMO-1-conjugated proteins contain zinc fingers. Although both SUMO family members play roles in many cellular processes, our data show that sumoylation is strongly associated with transcription because nearly one-third of the identified target proteins are putative transcriptional regulators.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17000644     DOI: 10.1074/mcp.M600212-MCP200

Source DB:  PubMed          Journal:  Mol Cell Proteomics        ISSN: 1535-9476            Impact factor:   5.911


  146 in total

1.  Isoform-specific monobody inhibitors of small ubiquitin-related modifiers engineered using structure-guided library design.

Authors:  Ryan N Gilbreth; Khue Truong; Ikenna Madu; Akiko Koide; John B Wojcik; Nan-Sheng Li; Joseph A Piccirilli; Yuan Chen; Shohei Koide
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-25       Impact factor: 11.205

2.  HPV E6 proteins target Ubc9, the SUMO conjugating enzyme.

Authors:  Phillip R Heaton; Adeline F Deyrieux; Xue-Lin Bian; Van G Wilson
Journal:  Virus Res       Date:  2011-04-12       Impact factor: 3.303

3.  Regulation of vaccinia virus E3 protein by small ubiquitin-like modifier proteins.

Authors:  José González-Santamaría; Michela Campagna; María Angel García; Laura Marcos-Villar; Dolores González; Pedro Gallego; Fernando Lopitz-Otsoa; Susana Guerra; Manuel S Rodríguez; Mariano Esteban; Carmen Rivas
Journal:  J Virol       Date:  2011-09-28       Impact factor: 5.103

4.  In Vitro Studies Reveal a Sequential Mode of Chain Processing by the Yeast SUMO (Small Ubiquitin-related Modifier)-specific Protease Ulp2.

Authors:  Julia Eckhoff; R Jürgen Dohmen
Journal:  J Biol Chem       Date:  2015-04-01       Impact factor: 5.157

5.  A novel proteomics approach to identify SUMOylated proteins and their modification sites in human cells.

Authors:  Frederic Galisson; Louiza Mahrouche; Mathieu Courcelles; Eric Bonneil; Sylvain Meloche; Mounira K Chelbi-Alix; Pierre Thibault
Journal:  Mol Cell Proteomics       Date:  2010-11-22       Impact factor: 5.911

Review 6.  An additional role for SUMO in ubiquitin-mediated proteolysis.

Authors:  Marie-Claude Geoffroy; Ronald T Hay
Journal:  Nat Rev Mol Cell Biol       Date:  2009-05-28       Impact factor: 94.444

7.  Novel proteomics strategy brings insight into the prevalence of SUMO-2 target sites.

Authors:  Henri A Blomster; Ville Hietakangas; Jianmin Wu; Petri Kouvonen; Sampsa Hautaniemi; Lea Sistonen
Journal:  Mol Cell Proteomics       Date:  2009-02-24       Impact factor: 5.911

8.  KRAB zinc-finger proteins localise to novel KAP1-containing foci that are adjacent to PML nuclear bodies.

Authors:  Stephanie Briers; Catherine Crawford; Wendy A Bickmore; Heidi G Sutherland
Journal:  J Cell Sci       Date:  2009-03-03       Impact factor: 5.285

9.  Dual modification of BMAL1 by SUMO2/3 and ubiquitin promotes circadian activation of the CLOCK/BMAL1 complex.

Authors:  Jiwon Lee; Yool Lee; Min Joo Lee; Eonyoung Park; Sung Hwan Kang; Chin Ha Chung; Kun Ho Lee; Kyungjin Kim
Journal:  Mol Cell Biol       Date:  2008-07-21       Impact factor: 4.272

10.  Ubiquitin-family modifications of topoisomerase I in camptothecin-treated human breast cancer cells.

Authors:  Ragu Kanagasabai; Shujun Liu; Samir Salama; Edith F Yamasaki; Liwen Zhang; Kari B Greenchurch; Robert M Snapka
Journal:  Biochemistry       Date:  2009-04-14       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.